Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
People from all different specialties have expressed that this really helps them to diagnose and manage PCOS because they don't have to try to keep everything in their head and feel overwhelmed, Dr
"This strategic collaboration advances our weight management portfolio by delivering novel assets which complement our existing programmes." "It will provide access to CSPCs proprietary AI-enabled peptide capabilities and platform technology, which have the potential to transform the treatment of obesity, helping to address adherence and convenience as key barriers to long-term therapeutic success." "This is an important step in creating a portfolio of simple, scalable and sustainable options that can help people with obesity and weight-related complications live better, healthier lives." CSPC Chairman Dongchen Cai added: "We are very excited to further expand and strengthen our strategic partnership with AstraZeneca into the area of weight management." "Obesity and related comorbidities represent a significant health challenge but also an opportunity." "We hope this win-win collaboration will deliver the next generation of treatments that build upon the emerging science, using our technology platforms and AstraZenecas complementary capabilities and reach, to realise global health benefits for people in need of improved weight management." Beyond the initial programmes, AstraZeneca will have the option to pursue additional metabolic assets using CSPCs LiquidGel once-monthly dosing platform, with rights to deploy the technology across its internal pipeline
Severe gastrointestinal adverse reactions may lead to dehydration and acute kidney injury, particularly in patients with pre-existing renal impairment, requiring close monitoring of fluid status and kidney function
A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF
The effect may be related to the metabolic improvements associated with this class of medications
Your SheMed clinician can advise on whether your current dose is appropriate to maintain or whether moving up is likely to add meaningful benefit
